Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribonuclease activity refers to the enzymatic or chemical process of cleaving RNA molecules by breaking the phosphodiester bonds in their sugar-phosphate backbone. This process is also known as RNA hydrolysis or RNA cleavage. The hydrolysis of RNA occurs when the 2'-hydroxyl (2'-OH) group on the ribose sugar acts as a nucleophile, attacking the adjacent phosphorus atom in the phosphodiester bond. This leads to cleavage of the ester bond and formation of a 2',3'-cyclic phosphate intermediate. Different RNases have distinct substrate preferences and biological roles. Ribonuclease activity plays essential roles in: degradation and turnover of cellular RNAs, processing precursor RNAs into mature forms, defense against viral infection via targeted degradation, maintenance of genome stability through removal of aberrant RNA:DNA hybrids (e.g., R-loops).
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribonuclease Activity (None).